Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens.

De La Cruz, Justin; Vardhanbhuti, Saran; Sahoo, Malaya K; Rovner, Robert; Bosch, Ronald J; Manasa, Justen; Katzenstein, David A; Pinsky, Benjamin A

De La Cruz, Justin; Vardhanbhuti, Saran; Sahoo, Malaya K; Rovner, Robert; Bosch, Ronald J; Manasa, Justen; Katzenstein, David A; Pinsky, Benjamin A.

Afiliación

De La Cruz J; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.
Vardhanbhuti S; Harvard TH Chan School of Public Health, Boston, Massachusetts.
Sahoo MK; Department of Pathology, Stanford University School of Medicine, California.
Rovner R; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.
Bosch RJ; Harvard TH Chan School of Public Health, Boston, Massachusetts.
Manasa J; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.
Katzenstein DA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.
Pinsky BA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine.

Open Forum Infect Dis ; 6(3): ofz034, 2019 Mar.

Article en En | MEDLINE | ID: mdl-30863788

Palabras clave

drug resistance mutations; efavirenz; nonnucleoside reverse-transcriptase inhibitors; proviral DNA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2019 Tipo del documento: Article